AI assistant
Sending…
PULSE BIOSCIENCES, INC. — Director's Dealing 2021
Jan 26, 2021
32093_dirs_2021-01-26_6a6faff5-8006-429c-8329-a8fad63ad121.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2021-01-25
Reporting Person: UECKER DARRIN (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-25 | Common Stock | X | 1284 | $7.01 | Acquired | 127893 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-25 | Warrant (right to buy) | $7.01 | X | 1284 | Disposed | 2025-06-15 | Common Stock (1284) | Direct |
More from PULSE BIOSCIENCES, INC.
Regulatory Filings
2026
Jun 10
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 11
Capital/Financing Update
2026
May 6
Earnings Release
2026
May 4
Investor Presentation
2026
Apr 27
Investor Presentation
2026
Apr 16
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 7
Board/Management Information
2026
Mar 27